Benjamin Holmes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Benjamin Holmes has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Lin Lin
Hubrecht Institute
2 shared publicationsDarnell Kammeron
Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht 3584 CT, the Netherlands
1 shared publicationDavid Gifford
Massachusetts Institute of Technology
1 shared publication- David Kenneth Gifford
Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, USA
1 shared publication - Feng Zhang
Howard Hughes Medical Institute, Cambridge, USA
1 shared publication - Hideto Mori
Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe), The University of Osaka, Osaka, Japan
1 shared publication
Latest Publications
- Open Access
“High resolution discovery of regulatory DNA with synthetic wild-type and ablated genome constructs”
Genomic enhancer elements play a role in modulating gene expression by interacting with effector proteins known as transcription factors. We present a new computational method, “STARR-scan”, which identifies transcription factor motif appearances in synthetic DNA constructs that are correlated with enhancer activity. Using a tiled STARR-seq assay, we demonstrate that STARR-scan can suggest the biological function of transcription factors previously suspected to activate the APOBEC-3B gene. Using the same methodology, STARR-scan can suggest transcription factors with previously unknown biological activity which may regulate the APOBEC-3B gene. These novel factors may have biological significance in our understanding of cancer biology.
Open Access“High resolution discovery of regulatory DNA with synthetic wild-type and ablated genome constructs”
Genomic enhancer elements play a role in modulating gene expression by interacting with effector proteins known as transcription factors. We present a new computational method, “STARR-scan”, which identifies transcription factor motif appearances in synthetic DNA constructs that are correlated with enhancer activity. Using a tiled STARR-seq assay, we demonstrate that STARR-scan can suggest the biological function of transcription factors previously suspected to activate the APOBEC-3B gene. Using the same methodology, STARR-scan can suggest transcription factors with previously unknown biological activity which may regulate the APOBEC-3B gene. These novel factors may have biological significance in our understanding of cancer biology.
- Open Access
- 1 November 2020
- Published by Elsevier in Cell Reports
- Vol. 33 (8) , 108426
Comprehensive Mapping of Key Regulatory Networks that Drive Oncogene Expression
- 1 November 2020
- Published by Elsevier in Cell Reports
- Vol. 33 (8) , 108426
Open AccessComprehensive Mapping of Key Regulatory Networks that Drive Oncogene Expression
- Top Cited Papers
- 21 September 2018
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 361 (6408) , 1259-1262
Engineered CRISPR-Cas9 nuclease with expanded targeting space
Expanding the targeting space of Cas9: CRISPR-Cas9 associates with a guide RNA to target and cleave a specific DNA site next to a protospacer adjacent motif (PAM). Streptococcus pyogenes Cas9 (SpCas9), the one most often used for genome editing, only recognizes the NGG sequence (where N is any nucleobase) as the PAM, which restricts regions in the genome that can be targeted. To address this limitation, Nishimasu et al. created a SpCas9 variant that recognizes NG rather than NGG. The SpCas9-NG variant increased the targeting range, had a specificity similar to that of the wild-type enzyme, and could be used with a base editor. Thus, SpCas9-NG is a powerful addition to the CRISPR-Cas9 genome engineering toolbox and will be useful in a broad range of applications, from basic research to clinical therapeutics. Science , this issue p. 1259
- 21 September 2018
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 361 (6408) , 1259-1262
Top Cited PapersEngineered CRISPR-Cas9 nuclease with expanded targeting space
Expanding the targeting space of Cas9: CRISPR-Cas9 associates with a guide RNA to target and cleave a specific DNA site next to a protospacer adjacent motif (PAM). Streptococcus pyogenes Cas9 (SpCas9), the one most often used for genome editing, only recognizes the NGG sequence (where N is any nucleobase) as the PAM, which restricts regions in the genome that can be targeted. To address this limitation, Nishimasu et al. created a SpCas9 variant that recognizes NG rather than NGG. The SpCas9-NG variant increased the targeting range, had a specificity similar to that of the wild-type enzyme, and could be used with a base editor. Thus, SpCas9-NG is a powerful addition to the CRISPR-Cas9 genome engineering toolbox and will be useful in a broad range of applications, from basic research to clinical therapeutics. Science , this issue p. 1259